Patents by Inventor Ann-Muriel STEFF

Ann-Muriel STEFF has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230390381
    Abstract: This disclosure provides immunogenic combinations that include a) an immunogenic component containing a peptide or polypeptide antigen of a respiratory pathogen; and b) an immunogenic component containing a nucleic acid encoding an antigen of the same respiratory pathogen, wherein the immunogenic components are formulated for concurrent, e.g., co-localized, administration. More specifically, the respiratory pathogen is respiratory syncytial virus (RSV). This disclosure also concerns provides the use of such immunogenic combinations, and methods for administering such immunogenic combinations to elicit an immune response specific for the respiratory pathogen.
    Type: Application
    Filed: December 15, 2022
    Publication date: December 7, 2023
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Ann-Muriel STEFF, Jean-Francois TOUSSAINT, Alessandra VITELLI
  • Patent number: 11571472
    Abstract: Immunogenic combinations that include a) an immunogenic component containing a peptide or polypeptide antigen of a respiratory pathogen; and b) an immunogenic component containing a nucleic acid encoding an antigen of the same respiratory pathogen, wherein the immunogenic components are formulated for concurrent administration are provided, as well as methods for making and for administering such immunogenic combinations to elicit an immune response specific for the respiratory pathogen.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: February 7, 2023
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Ann-Muriel Steff, Jean-Francois Toussaint, Alessandra Vitelli
  • Publication number: 20170143820
    Abstract: Immunogenic combinations that include a) an immunogenic component containing a peptide or polypeptide antigen of a respiratory pathogen; and b) an immunogenic component containing a nucleic acid encoding an antigen of the same respiratory pathogen, wherein the immunogenic components are formulated for concurrent administration are provided, as well as methods for making and for administering such immunogenic combinations to elicit an immune response specific for the respiratory pathogen.
    Type: Application
    Filed: June 12, 2015
    Publication date: May 25, 2017
    Applicant: GLAXOSMITHKLINE SA
    Inventors: Ann-Muriel STEFF, Jean-Francois TOUSSAINT, Alessandra VITELLI
  • Publication number: 20160193322
    Abstract: Combination immunogenic compositions capable of eliciting protection against both RSV and B. pertussis infection and disease are provided, including compositions which comprise a recombinant F protein analog of RSV, together with B. pertussis acellular (Pa) or whole cell (Pw) antigens.
    Type: Application
    Filed: August 4, 2014
    Publication date: July 7, 2016
    Inventors: Ann-Muriel STEFF, Stéphane T. TEMMERMAN, Jean-François TOUSSAINT
  • Publication number: 20150202283
    Abstract: This disclosure provides methods for protecting infants against disease caused by respiratory syncytial virus (RSV) and Bordetella pertussis through maternal immunization using recombinant respiratory syncytial virus (RSV) and B. pertussis antigens to reduce the incidence or severity of RSV and pertussis infection in young infants.
    Type: Application
    Filed: August 5, 2013
    Publication date: July 23, 2015
    Inventors: Ann-Muriel Steff, Stephane T. Temmerman, Jean-Francois Toussaint
  • Publication number: 20140037680
    Abstract: This disclosure provides methods for protecting infants against disease caused by respiratory syncytial virus (RSV) through maternal immunization using recombinant respiratory syncytial virus (RSV) antigens to reduce the incidence or severity of RSV infection in young infants.
    Type: Application
    Filed: March 15, 2013
    Publication date: February 6, 2014
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, S.A.
    Inventors: Ann-Muriel STEFF, Jean-Francios TOUSSAINT